Ranger International Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Ranger International Management's ABBV Position: Q2 2017 in Review
Ranger International Management increased its AbbVie (ABBV) stake by 13% in Q2 2017, buying an estimated $93.4K and bringing the position to 11,735 shares worth $851K. The position accounts for 3.88% of the portfolio, ranked #9.
Ranger International Management first reported a position in ABBV in Q2 2016 and has held it in 5 quarters since. The position peaked at $5.71M in Q3 2016. 1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.
- Ranger International Management held 11,735 shares of AbbVie worth $851K as of Q2 2017.
- Ranger International Management bought 1,390 AbbVie shares in Q2 2017, an estimated $93.4K.
- AbbVie made up 3.88% of Ranger International Management's portfolio in Q2 2017, its #9 holding.
- Ranger International Management first reported a position in AbbVie in Q2 2016 and has held it in 5 quarters since.
- Ranger International Management's AbbVie position peaked at $5.71M in Q3 2016.
- 1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.
Based on Ranger International Management's 13F filing for Q2 2017, filed 14 Aug 2017.